AFC-HD AMS Life Science Co., Ltd. (TYO:2927)
Japan
· Delayed Price · Currency is JPY 900.00
+9.00 (1.01%)
Mar 10, 2026, 3:30 PM JST
AFC-HD AMS Life Science Cash Flow Statement
Financials in millions JPY. Fiscal year is September - August.
Millions JPY. Fiscal year is Sep - Aug.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Nov '25 Nov 30, 2025 | Aug '25 Aug 31, 2025 | Aug '24 Aug 31, 2024 | Aug '23 Aug 31, 2023 | Aug '22 Aug 31, 2022 | Aug '21 Aug 31, 2021 | 2020 - 2016 |
| Net Income | - | 2,200 | 1,910 | 1,545 | 1,235 | 2,157 | Upgrade
|
| Depreciation & Amortization | - | 1,396 | 1,084 | 983 | 1,005 | 648 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | 426 | -22 | 31 | 88 | 4 | Upgrade
|
| Loss (Gain) From Sale of Investments | - | -11 | -47 | -44 | -10 | 3 | Upgrade
|
| Other Operating Activities | - | -756 | -567 | -318 | -679 | -302 | Upgrade
|
| Change in Accounts Receivable | - | -147 | 156 | -206 | -332 | 294 | Upgrade
|
| Change in Inventory | - | -890 | -1,433 | -633 | 123 | -361 | Upgrade
|
| Change in Accounts Payable | - | -58 | 351 | -261 | 679 | -181 | Upgrade
|
| Change in Other Net Operating Assets | - | -374 | 108 | -232 | -617 | 320 | Upgrade
|
| Operating Cash Flow | - | 1,786 | 1,540 | 865 | 1,492 | 2,582 | Upgrade
|
| Operating Cash Flow Growth | - | 15.97% | 78.03% | -42.02% | -42.22% | 98.77% | Upgrade
|
| Capital Expenditures | - | -3,538 | -3,406 | -1,939 | -957 | -491 | Upgrade
|
| Sale of Property, Plant & Equipment | - | 44 | 658 | - | 3 | 3 | Upgrade
|
| Cash Acquisitions | - | - | 162 | -114 | 2 | 1 | Upgrade
|
| Investment in Securities | - | 151 | -188 | 254 | 388 | 147 | Upgrade
|
| Other Investing Activities | - | 17 | 13 | 64 | -513 | 66 | Upgrade
|
| Investing Cash Flow | - | -3,326 | -2,761 | -1,946 | -1,077 | -274 | Upgrade
|
| Short-Term Debt Issued | - | 1,065 | 1,003 | 1,093 | 2,853 | - | Upgrade
|
| Long-Term Debt Issued | - | 1,357 | 2,172 | 1,684 | 635 | 9,500 | Upgrade
|
| Total Debt Issued | - | 2,422 | 3,175 | 2,777 | 3,488 | 9,500 | Upgrade
|
| Short-Term Debt Repaid | - | - | - | - | - | -1,210 | Upgrade
|
| Long-Term Debt Repaid | - | -1,177 | -487 | -380 | -1,034 | -5,581 | Upgrade
|
| Total Debt Repaid | - | -1,177 | -487 | -380 | -1,034 | -6,791 | Upgrade
|
| Net Debt Issued (Repaid) | - | 1,245 | 2,688 | 2,397 | 2,454 | 2,709 | Upgrade
|
| Repurchase of Common Stock | - | -13 | - | -79 | -288 | -152 | Upgrade
|
| Common Dividends Paid | - | -434 | -418 | -385 | -421 | -312 | Upgrade
|
| Other Financing Activities | - | -132 | -38 | -52 | -586 | -60 | Upgrade
|
| Financing Cash Flow | - | 666 | 2,232 | 1,881 | 1,159 | 2,185 | Upgrade
|
| Foreign Exchange Rate Adjustments | - | 2 | -2 | 3 | 16 | 3 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | - | 2 | -1 | 1 | - | - | Upgrade
|
| Net Cash Flow | - | -870 | 1,008 | 804 | 1,590 | 4,496 | Upgrade
|
| Free Cash Flow | - | -1,752 | -1,866 | -1,074 | 535 | 2,091 | Upgrade
|
| Free Cash Flow Growth | - | - | - | - | -74.41% | 127.78% | Upgrade
|
| Free Cash Flow Margin | - | -5.37% | -6.18% | -4.20% | 2.33% | 9.35% | Upgrade
|
| Free Cash Flow Per Share | - | -124.54 | -132.80 | -76.43 | 37.89 | 148.62 | Upgrade
|
| Cash Interest Paid | - | 193 | 97 | 58 | 58 | 31 | Upgrade
|
| Cash Income Tax Paid | - | 798 | 575 | 282 | 993 | 321 | Upgrade
|
| Levered Free Cash Flow | - | -2,330 | -1,029 | -1,497 | -66.13 | 3,658 | Upgrade
|
| Unlevered Free Cash Flow | - | -2,205 | -965.5 | -1,461 | -30.5 | 3,689 | Upgrade
|
| Change in Working Capital | - | -1,469 | -818 | -1,332 | -147 | 72 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.